Does rectal diclofenac reduce post-ERCP pancreatitis? A district general hospital experience
Sign Up to like & getrecommendations! Published in 2017 at "Frontline Gastroenterology"
DOI: 10.1136/flgastro-2017-100832
Abstract: Introduction There is controversy in the literature recently regarding the efficacy of rectal non-steroidal anti-inflammatory drugs (NSAID) to prevent post-ERCP pancreatitis (PEP). The aim of this study was to compare the incidence of PEP in… read more here.
Keywords: pancreatitis; use; hospital; rectal diclofenac ... See more keywords